Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
Sarah K. Tasian(Children's Hospital of Philadelphia), Stephan A. Grupp(Children's Hospital of Philadelphia)
Cited by 163
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
|Blood|2015|718
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
|Cancer Discovery|2020|297
FOXO1 is a master regulator of memory programming in CAR T cells
|Nature|2024|189